Marc Carrier, MD, MSc, FRCPC
Ottawa Hospital Research Institute · Ottawa Hospital Research Institute / Division of Hematology- The Ottawa Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Marc Carrier, MD, MSc, FRCPC as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:45 UTC. Open this list on ClinicalTrials.gov
- Ph2/Ph3NCT06662253 · Anti-Xa Guided Dosing of Low Molecular Weight Heparin for Prevention of Venous Thromboembolism Following Traumatic Injury: a Multicentre Pilot Randomized TrialAlexandre Tran · unknown · Venous Thromboembolism (VTE), Trauma Related Injuries · principal investigator
- Ph3NCT06440694 · Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)Ottawa Hospital Research Institute · recruiting · Venous Thromboembolism · principal investigator
- N/ANCT00773448 · Screening for Occult Malignancy in Patients With Idiopathic Venous ThromboembolismOttawa Hospital Research Institute · completed · Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:45 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.